Representative Matters
REFERENZMANDATE
代表事项
Venture Financings
- Vedere Bio II in its $77 million Series A financing
- Triplet Therapeutics in its $49 million Series A financing
- Quentis Therapeutics in its $48 million Series A financing
- Cadent Therapeutics in its $40 million Series B financing
- Hodinkee in its $40 million Series B financing
- LeafLink in its $35 million Series B financing
- Alto Solutions in its $17 million Series A financing
- Noodle Partners in its $16 million Series B financing
- Two Sigma Ventures’ investment in Remote Technology, Inc’s $11 million Series Seed financing
- Digital+ Partners’ investment in ChartIQ, Inc.’s $17 million Series B financing
- Batu Capital Investments’ investment in MJ Freeway, LLC’s $10 million Series C financing
Mergers and Acquisitions
- LaSalle Hotel Properties in a $5.2 billion merger with Pebblebrook Hotel Trust
- TripleLift in its $1.4 billion acquisition by Vista Equity Partners
- Kensho Technologies in its $550 million acquisition by S&P Global
- Lennar Corporation in the sale of its SunStreet solar platform to Sunnova Energy
- Johnson & Johnson in the sale of its BabyCenter business to Everyday Health Group
- Plug Power in its $58 million acquisition of Giner ELX, Inc.
- Plug Power in its $65 million acquisition of United Hydrogen Group Inc.
- Vedere Bio in its $280 million acquisition by Novartis
- OncoImmune in its $425 million acquisition (plus undisclosed milestone payments) by Merck
Public Offerings
- SpringWorks Therapeutics, Inc. in its $186.3 million initial public offering
- Cowen and Company and William Blair as underwriters in a $32.5 million follow-on offering for Ovid Therapeutics Inc.
- Oppenheimer & Co. Inc. as underwriters in a $15.4 million follow-on public offering for BioLineRx, Inc.
- Stifel, Nicolaus & Company as underwriters in a $11.5 million follow-on public offering for IRIDEX Corporation
Professional Activities
Mr. Hays serves as the New York Co-Chair of Goodwin’s Neighborhood Business Initiative (NBI), a program created to provide pro bono legal services to low-income entrepreneurs and small business owners in underserved communities.
Mr. Hays is a member of the Board of Directors of the scientific research institute PSE Healthy Energy (Physicians, Scientists & Engineers) and a member of the Board of Directors of Artists with Evidence, a nonprofit that commissions artists and scientists to collaborate, explore and exhibit art works.Professional Experience
Prior to joining Goodwin, Mr. Hays served as the Director of the Environmental Health Program at PSE Healthy Energy and as a research associate at Weill Cornell Medicine.